Current Ratio of SUPERNUS PHARMACEUTICALS, INC. from 30 Sep 2012 to 31 Dec 2025
- Taxonomy & unit
- ratio: x
- Description
- The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
- Summary
-
SUPERNUS PHARMACEUTICALS, INC. quarterly Current Ratio in x history and change rate from 30 Sep 2012 to 31 Dec 2025.
- SUPERNUS PHARMACEUTICALS, INC. Current Ratio for the quarter ending 31 Dec 2025 was 2.15x, a 5.6% increase year-over-year.
Current Ratio, Quarterly (x)
Current Ratio, YoY Quarterly Change (%)
SUPERNUS PHARMACEUTICALS, INC. Quarterly Current Ratio (x)
| Period | Value | YoY Chg | Change % | Date |
|---|---|---|---|---|
| Q4 2025 | 2.15x | +0.12x | +5.6% | 31 Dec 2025 |
| Q3 2025 | 2.27x | +0.39x | +21% | 30 Sep 2025 |
| Q2 2025 | 2.39x | +0.66x | +38% | 30 Jun 2025 |
| Q1 2025 | 2.22x | +0.55x | +33% | 31 Mar 2025 |
| Q4 2024 | 2.04x | +0.6x | +42% | 31 Dec 2024 |
| Q3 2024 | 1.88x | +0.61x | +48% | 30 Sep 2024 |
| Q2 2024 | 1.73x | +0.6x | +53% | 30 Jun 2024 |
| Q1 2024 | 1.67x | +0.66x | +65% | 31 Mar 2024 |
| Q4 2023 | 1.44x | +0.38x | +35% | 31 Dec 2023 |
| Q3 2023 | 1.27x | +0.08x | +6.5% | 30 Sep 2023 |
| Q2 2023 | 1.13x | -0.44x | -28% | 30 Jun 2023 |
| Q1 2023 | 1.01x | -1.21x | -54% | 31 Mar 2023 |
| Q4 2022 | 1.06x | -1.26x | -54% | 31 Dec 2022 |
| Q3 2022 | 1.19x | -1.32x | -53% | 30 Sep 2022 |
| Q2 2022 | 1.57x | -0.68x | -30% | 30 Jun 2022 |
| Q1 2022 | 2.22x | +0.01x | +0.51% | 31 Mar 2022 |
| Q4 2021 | 2.32x | -0.02x | -0.66% | 31 Dec 2021 |
| Q3 2021 | 2.51x | +0.13x | +5.5% | 30 Sep 2021 |
| Q2 2021 | 2.25x | -0.44x | -16% | 30 Jun 2021 |
| Q1 2021 | 2.2x | -0.76x | -26% | 31 Mar 2021 |
| Q4 2020 | 2.34x | -0.48x | -17% | 31 Dec 2020 |
| Q3 2020 | 2.38x | -0.47x | -17% | 30 Sep 2020 |
| Q2 2020 | 2.69x | -0.15x | -5.4% | 30 Jun 2020 |
| Q1 2020 | 2.97x | +0.11x | +3.7% | 31 Mar 2020 |
| Q4 2019 | 2.82x | -0.53x | -16% | 31 Dec 2019 |
| Q3 2019 | 2.85x | -0.22x | -7% | 30 Sep 2019 |
| Q2 2019 | 2.85x | -0.01x | -0.29% | 30 Jun 2019 |
| Q1 2019 | 2.86x | +0.16x | +5.9% | 31 Mar 2019 |
| Q4 2018 | 3.35x | +1.49x | +80% | 31 Dec 2018 |
| Q3 2018 | 3.07x | +1.21x | +65% | 30 Sep 2018 |
| Q2 2018 | 2.86x | +0.96x | +51% | 30 Jun 2018 |
| Q1 2018 | 2.7x | +0.87x | +47% | 31 Mar 2018 |
| Q4 2017 | 1.86x | +0.05x | +2.9% | 31 Dec 2017 |
| Q3 2017 | 1.86x | +0.07x | +3.6% | 30 Sep 2017 |
| Q2 2017 | 1.89x | +0.03x | +1.5% | 30 Jun 2017 |
| Q1 2017 | 1.83x | -0.28x | -13% | 31 Mar 2017 |
| Q4 2016 | 1.81x | -0.72x | -28% | 31 Dec 2016 |
| Q3 2016 | 1.8x | -1.28x | -42% | 30 Sep 2016 |
| Q2 2016 | 1.86x | -1.8x | -49% | 30 Jun 2016 |
| Q1 2016 | 2.12x | -1.85x | -47% | 31 Mar 2016 |
| Q4 2015 | 2.52x | -1.24x | -33% | 31 Dec 2015 |
| Q3 2015 | 3.08x | -0.63x | -17% | 30 Sep 2015 |
| Q2 2015 | 3.66x | +0.06x | +1.7% | 30 Jun 2015 |
| Q1 2015 | 3.97x | -0.16x | -3.8% | 31 Mar 2015 |
| Q4 2014 | 3.76x | -0.33x | -8.1% | 31 Dec 2014 |
| Q3 2014 | 3.71x | -0.47x | -11% | 30 Sep 2014 |
| Q2 2014 | 3.6x | -0.17x | -4.4% | 30 Jun 2014 |
| Q1 2014 | 4.13x | +0.93x | +29% | 31 Mar 2014 |
| Q4 2013 | 4.09x | +1.07x | +35% | 31 Dec 2013 |
| Q3 2013 | 4.19x | +1.5x | +56% | 30 Sep 2013 |
| Q2 2013 | 3.77x | 30 Jun 2013 | ||
| Q1 2013 | 3.2x | 31 Mar 2013 | ||
| Q4 2012 | 3.03x | 31 Dec 2012 | ||
| Q3 2012 | 2.68x | 30 Sep 2012 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.